Medium urgency
--
This is a much rarer variant of Guillain-Barré syndrome (autoimmune destruction of the myelin sheath of nerves), characterized by rapidly evolving ophthalmoplegia (partial paralysis of the eyes), ataxia (uncoordinated limbs) and areflexia (lack of muscle reflexes) without weakness. It can sometimes simulate a medullary stroke, although the onset of a stroke is sudden whereas this syndrome is progressive. Alternatively, it may simulate botulism due to its progression down the body. A suspected diagnosis is established on the basis of the clinical symptoms, to be confirmed with a blood antibodies test. A positive 2-4 week prognosis can generally be expected but hospital care is required in the event of deterioration and for initiating treatment with immunoglobulins or plasmapheresis, as with the treatment for Guillain-Barré syndrome.
- Francine J Vriesendorp, MD. Clinical features and diagnosis of Guillain-Barré syndrome in adults. UpToDate. Jun 15, 2016.
- Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 2007; 36:615.
- Winer JB. Bickerstaff's encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2001; 71:433.
- Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol 2004; 148:200.
- Maslanka S. Rao AK. Botulismo. Harrison. Principios de Medicina Interna. Volumen 2. 19º Edición: 989.
- Hauser SL. Amato AA. Síndrome de Guillain-Barré y otras neuropatías mediadas por mecanismos inmunitarios. Harrison. Principios de Medicina Interna. Volumen 2. 19º Edición: 2694-2698.
Dr. Sara Vitoria
Copyright© TeckelMedical 2026

